Fumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes

British Journal of Dermatology

Volumn 131, Issue 6, 1994, Pages 856-861

  THIO, H B ^a   ZOMERDIJK, T P L ^a   OUDSHOORN, C ^a   KEMPENAAR, J ^a   NIBBERING, P H ^a   van der SCHROEFF, J G ^b   PONEC, M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EGTAZIC ACID; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; FUMARIC ACID METHYL ESTER; MALONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; CALCIUM; CELL DIVISION; CELL LINE, TRANSFORMED; CELLS, CULTURED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FUMARATES; HUMAN; INTRACELLULAR FLUID; KERATINOCYTES; LACTATE DEHYDROGENASE; MALE; MALEATES;

EID: 0028089856     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1994.tb08589.x     Document Type: Article

References (35)

1. Fumarsäure bei Psoriasis vulgaris
2. Perorale Langzeitbehandlung der Psoriasis mit Fumarsäurederivaten
3. Psoriasis‐Behandlung mit Fumarsäure und Fumarsäureestern
4. Systemic therapy with fumaric acid derivatives: new possibilities in the treatment of psoriasis
5. Heilung von Psoriasis vulgaris
6. Fumarsäure lindert die Schuppenflechte
7. Fumaric acid therapy for psoriasis: a randomized, double‐blind, placebo‐controlled study
8. Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment
9. Akute Niereninsuffizienz bei der Behandlung der Psoriasis mit Fumarsäure‐Estern
10. Nephrotoxische Wirkung einer Therapie mit Fumarsäueestern bei Psoriasis
11. Akute Nierenversagen unter Psoriasistherapie mit Fumarsäurederivaten
12. A defective purine nucleotide synthesis pathway in psoriatic patients
13. Decreased protein kinase C activity in psoriatic versus normal epidermis
14. Cyclic AMP is decreased in mononuclear leucocytes from psoriasis patients
15. Cyclic AMP and cyclic GMP production in normal and psoriatic epidermis
16. Protein kinase C activity in normal and psoriatic cells: cultures of fibroblasts and lymphocytes
17. Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8‐azido cyclic AMP binding to the RI regulatory subunit
18. Effects of monomethylfumarate on human granulocytes
19. Serial cultivation of normal human epidermal keratinocytes
20. Calcium‐mediated regulation of the low density lipoprotein receptor and intracellular cholesterol synthesis in human epidermal keratinocytes
21. Effects of SV 40 transformation on the cytoskeleton and behavioural properties of human keratinocytes
22. Defective low‐density lipoprotein metabolism in cultured, normal, transformed, and malignant keratinocytes
23. Calcium regulation of growth and differentiation of mouse epidermal cells in culture
24. Fluorescence and bioluminescence measurement of cytoplasmic free calcium
25. The calcium signal
26. Isolation, purification and characterization of bovine epidermal transglutaminase
27. 2+‐dependent protein phosphorylation system in membranes from various tissues, and its activation by ‘calcium‐dependent regulator
28. Signal transduction for proliferation and differentiation in keratinocytes
29. Membrane transport of calcium: an overview
30. 2+‐induced keratinocyte terminal differentiation in vitro
31. Spatial and temporal aspects of cell signalling
32. i) increases in neonatal foreskin keratinocytes
33. 3 increases intracellular calcium in human keratinocytes
34. Dimethyl and monoethyl fumarates but not fumaric acid exert antiproliferative activities on keratinocytes